Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

NCT04351659 is registered in ClinicalTrials.gov with KK Women's and Children's Hospital as lead sponsor.

NCT NCT04351659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04351659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
Lead sponsor
KK Women's and Children's Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 14, 2020
Completion date
September 30, 2022
Enrollment
8 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19